Monthly Prescribing Reference

Tremfya Approved for Children With Plaque Psoriasis, Psoriatic Arthritis

The recommended dosage for active PsA and moderate to severe plaque PsO in pediatric patients 6 years (≥40kg) is 100mg administered SC at week 0, 4, and then every 8 weeks thereafter. The Food and ...
MPR

Qivigy Approved for Primary Humoral Immunodeficiency in Adults

Qivigy (immune globulin intravenous, human-kthm) is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin for IV administration.
Monthly Prescribing Reference

Trastuzumab Deruxtecan Superior to T-DM1 in High-Risk HER2+ Early Breast Cancer

Treatment with T-DXd resulted in a statistically significant and clinically meaningful improvement in IDFS vs T-DM1. Topline results were announced from a phase 3 trial comparing fam-trastuzumab ...
MPR

Mediterranean Diet Tied to Improvement in Psoriasis

HealthDay News — A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical therapy, according to a study ...
Monthly Prescribing Reference

Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions

Private equity hospitals reduced ED and ICU salary expenditures by 18.2 and 15.9% per inpatient bed day after acquisition, respectively. HealthDay News — hospitals that undergo private equity ...
MPR

Sprout Organics Widens Recall of Baby Food Pouches for Possible Lead

HealthDay News — Sprout Organics has widened its recall of 3.5-ounce Sweet Potato, Apple & Spinach pouches because some lots may contain elevated levels of lead. The Food and Drug Administration (FDA) ...
MPR

Prevention Strategies Developed for Cardiovascular Manifestations of COVID

HealthDay News — Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online September 18 in the European Journal of Preventive ...
MPR

Acute Cystitis Tied to Higher Risk for Urogenital Cancers

HealthDay News — Acute cystitis may signal the presence of urogenital cancers in middle-aged adults, according to a study published online September 16 in BMJ Public Health.
MPR

FDA Clears Eyeglass Lenses to Slow Myopia Progression in Children

The Food and Drug Administration (FDA) has cleared the Essilor Stellest eyeglass lenses to slow the progression of myopia, with or without astigmatism, in children aged 6 to 12 years at the initiation ...
Monthly Prescribing Reference

Guidance Issued on Impact, Management of Potassium, Phosphorus in CKD

Potassium additives may be beneficial for patients at low risk for hyperkalemia, while phosphorus additives offer no health benefits. HealthDay News — Guidance is presented for understanding the ...
MPR

Wrist Cooling May Help Manage Vasomotor Symptoms

HealthDay News — Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online September 20 in Endocrinology and Diabetes.
MPR

Palsonify, an Oral Therapy for Acromegaly, Gets FDA Approval

The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...